GW7647
SIGMA/G6793 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 265129-71-3
Empirical Formula (Hill Notation): C29H46N2O3S
Molecular Weight: 502.75
MDL Number: MFCD06798379
Linear Formula: C29H46N2O3S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| InChI | 1S/C29H46N2O3S/c1-29(2,27 |
| InChI key | PKNYXWMTHFMHKD-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | CC(C)(Sc1ccc(CCN(CCCCC2CC |
| solubility | DMSO: soluble 16 mg/mL |
| H2O: insoluble |
| Application: | GW7647 has been used as a peroxisome proliferator-activated receptor α (PPAR α) ligand: • in defatting medium to treat primary human hepatocytes • to test its effect on the glycolytic function in cardiomyocytes • to test its effect on infant mouse heart • in breast cancer MDA-MB-231 cells to activate PPARs |
| Biochem/physiol Actions: | GW7647 reduces serum triglyceride levels and enhances hepatic expression of genes associated with β-oxidation. Usage of GW7647 along with metformin in conditions of liver steatosis or injury improves the enzymatic levels of aspartate transaminase (AST) and alanine transaminase (ALT) in serum. |
| Biochem/physiol Actions: | Potent human PPARα agonist. Use to study the biology of PPARα receptor in human cells. |
| Features and Benefits: | This compound is featured on the Nuclear Receptors (PPARs) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Legal Information: | Sold for research purposes only under agreement from GlaxoSmithKline |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| UNSPSC | 12352200 |

